Alterations in PD-L1<sup>+</sup> Myeloid Cells and Immune Infiltration Are Associated with Atezolizumab and Paclitaxel Therapy Success in a Triple-Negative Breast Cancer Model.

Medicina (Kaunas) · 2026 · PMC13028344 · PMID 41901681

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

There was also a significant trend of PD-L1 increase on CD206 + macrophage surfaces found in immune organs such as lymph nodes and the spleen ( Figure 1 A–C). 3.2.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Alterations in PD-L1&lt;sup&gt;+&lt;/sup&gt; Myeloid Cells and Immune Infiltration Are Associated with Atezolizumab and Paclitaxel Therapy Success in a Triple-Negative Breast Cancer Model.

The sentences

Alterations in PD-L1<sup>+</sup> Myeloid Cells and Immune Infiltration Are Associated with Atezolizumab and Paclitaxel Therapy Success in a Triple-Negative Breast Cancer Model.